For the year ending 2025-11-30, NRIX has $688,135K in assets. $149,388K in debts. $246,960K in cash and cash equivalents.
| Balance Sheets | 2025-11-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 246,960 | |||
| Marketable securities | 345,981 | |||
| Prepaid expenses and other current assets | 13,878 | |||
| Total current assets | 606,819 | |||
| Operating lease right-of-use assets | 50,517 | |||
| Property and equipment, net | 22,490 | |||
| Restricted cash | 968 | |||
| Other assets | 7,341 | |||
| Total assets | 688,135 | |||
| Accounts payable | 11,215 | |||
| Accrued expenses and other current liabilities | 54,852 | |||
| Operating lease liabilities, current | 2,824 | |||
| Deferred revenue, current | 17,580 | |||
| Total current liabilities | 86,471 | |||
| Operating lease liabilities, net of current portion | 52,906 | |||
| Deferred revenue, net of current portion | 10,011 | |||
| Total liabilities | 149,388 | |||
| Common stock, 0.001 par value 500,000,000 shares authorized as of november30, 2025 and 2024 101,807,484 and 75,870,718 shares issued and outstanding as of november30, 2025 and 2024, respectively | 102 | |||
| Additional paid-in capital | 1,541,766 | |||
| Accumulated other comprehensive income | 105 | |||
| Accumulated deficit | -1,003,226 | |||
| Total stockholders equity | 538,747 | |||
| Total liabilities and stockholders equity | 688,135 | |||
Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX)